A government-sponsored study published recently in The Open Neurology Journal concludes that cannabis provides relief to some chronic pain sufferers and that more clinical trials are needed—directly challenging DEA classification of the drug under "Schedule I," that reserved for substances with no medical uses. The study, sponsored by the State of California and conducted at the University of California Center for Medicinal Cannabis Research, calls the Schedule I placement "not accurate" and "not tenable."
Recent comments
1 week 20 hours ago
2 weeks 1 day ago
2 weeks 1 day ago
23 weeks 1 day ago
27 weeks 2 days ago
29 weeks 1 hour ago
29 weeks 20 hours ago
41 weeks 3 days ago
47 weeks 1 day ago
1 year 6 weeks ago